Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Non Operating Investment Income (2021 - 2022)

Historic Non Operating Investment Income for ProPhase Labs (PRPH) over the last 2 years, with Q1 2022 value amounting to $37000.0.

  • ProPhase Labs' Non Operating Investment Income rose 43636.36% to $37000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $37000.0, marking a year-over-year change of. This contributed to the annual value of -$76000.0 for FY2022, which is 6833.33% up from last year.
  • ProPhase Labs' Non Operating Investment Income amounted to $37000.0 in Q1 2022, which was up 43636.36% from -$67000.0 recorded in Q2 2021.
  • Over the past 5 years, ProPhase Labs' Non Operating Investment Income peaked at $37000.0 during Q1 2022, and registered a low of -$67000.0 during Q2 2021.